Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 3,371 | 4,240 | 4,879 | 4,426 | 4,156 |
| Operating Income | -3,371 | -4,240 | -4,879 | -4,426 | -4,156 |
| Interest Expense | 426 | 102 | 230 | 34 | 142 |
| Other Income | 2,168 | 495 | 3,470 | 13 | 1,918 |
| Pre-tax Income | -1,629 | -3,847 | -1,639 | -4,447 | -2,380 |
| Income Tax | N/A | -4 | N/A | N/A | N/A |
| Net Income Continuous | -1,629 | -3,843 | -1,722 | -4,447 | -2,380 |
| Net Income | $-1,629 | $-3,843 | $-1,722 | $-4,447 | $-2,380 |
| EPS Basic Total Ops | -3.30 | -664.86 | 201,837.50 | -1,345.35 | -15,781.68 |
| EPS Basic Continuous Ops | -3.27 | -658.46 | 191,972.10 | -1,079.14 | -3,838.22 |
| EPS Diluted Total Ops | -3.30 | -664.86 | 201,837.50 | -1,345.35 | -15,781.68 |
| EPS Diluted Continuous Ops | -3.27 | -658.46 | 191,972.10 | -1,079.14 | -3,838.22 |
| EPS Diluted Before Non-Recurring Items | -3.30 | -664.86 | N/A | -1,345.35 | -15,783.78 |
| EBITDA(a) | $-3,370 | $-4,238 | $-4,870 | $-4,417 | $-4,147 |